Free Trial

Maximus, Inc. $MMS Shares Purchased by Wellington Management Group LLP

Maximus logo with Business Services background

Key Points

  • Wellington Management Group LLP increased its stake in Maximus, Inc. by 36.7% during Q1, now holding around $30.11 million in shares, which comprises approximately 0.78% of the company's total stock.
  • Maximus reported a Q2 EPS of $2.16, surpassing analysts' expectations of $1.39, with a revenue of $1.35 billion against estimates of $1.29 billion, representing a 2.5% increase compared to the previous year.
  • A quarterly dividend of $0.30 is set to be paid to shareholders, corresponding to an annual yield of 1.4% and a dividend payout ratio of 22.10%.
  • Need better tools to track Maximus? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Wellington Management Group LLP boosted its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 36.7% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 441,550 shares of the health services provider's stock after buying an additional 118,503 shares during the quarter. Wellington Management Group LLP owned 0.78% of Maximus worth $30,109,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Captrust Financial Advisors purchased a new stake in shares of Maximus during the fourth quarter valued at $276,000. GAMMA Investing LLC boosted its stake in shares of Maximus by 67.1% during the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after purchasing an additional 294 shares during the period. Blue Trust Inc. boosted its stake in shares of Maximus by 32.8% during the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock valued at $84,000 after purchasing an additional 303 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Maximus during the first quarter valued at $2,115,000. Finally, Janney Montgomery Scott LLC boosted its stake in shares of Maximus by 70.5% during the first quarter. Janney Montgomery Scott LLC now owns 10,145 shares of the health services provider's stock valued at $692,000 after purchasing an additional 4,196 shares during the period. 97.21% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Gayathri Rajan sold 7,913 shares of the company's stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the transaction, the director owned 14,205 shares in the company, valued at $1,028,157.90. This represents a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.60% of the stock is currently owned by company insiders.

Maximus Stock Up 0.1%

Maximus stock traded up $0.10 during trading hours on Thursday, reaching $87.66. The stock had a trading volume of 552,291 shares, compared to its average volume of 571,881. The company has a market cap of $4.94 billion, a price-to-earnings ratio of 16.14 and a beta of 0.60. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. The business's 50 day moving average price is $75.55 and its 200-day moving average price is $71.38. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.94.

Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm's revenue was up 2.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Sell-side analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be issued a dividend of $0.30 per share. The ex-dividend date is Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. Maximus's dividend payout ratio is 22.10%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on MMS shares. Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th. Zacks Research raised shares of Maximus from a "hold" rating to a "strong-buy" rating in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Strong Buy" and an average price target of $90.00.

Check Out Our Latest Analysis on Maximus

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Read More

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines